Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 31 of 114

  1. Cognitive Behavioral Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 3 other completed

    1 trial

  2. Cohort 1: Lubiprostone Capsule, Fasted

    Takeda

    Healthy Volunteers

    phase 3 small molecule completed

    1 trial

  3. Colchicine 0.5 mg

    The George Institute

    Intracerebral Hemorrhage

    phase 3 small molecule active

    1 trial

  4. Cold Stored Platelets

    United Therapeutics Europe Ltd

    Acute Blood Loss

    phase 3 mab completed

    1 trial

  5. Combination Treatment of PDS0101 and Pembrolizumab

    PDS Biotechnology Corp

    Recurrent Head and Neck Cancer

    phase 3 other active

    1 trial

  6. Combined use of TPO-RAs with low-dose anti-CD20 antibody

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immune Thrombocytopenia (ITP)

    phase 3 small molecule active

    1 trial

  7. Compound Realgar-Indigo Naturalis Formula Plus Retinoic Acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Promyelocytic Leukaemia

    phase 3 small molecule active

    1 trial

  8. Conceptrol

    Evofem Biosciences

    Contraception

    phase 3 small molecule completed

    1 trial

  9. Concizumab

    Novo Nordisk A/S

    Haemophilia A With Inhibitors

    phase 3 small molecule active

    1 trial

  10. Concizumab

    Novo Nordisk A/S

    Haemophilia A Without Inhibitors

    phase 3 small molecule active

    1 trial

  11. Concurrent chemotherapy

    Disc Medicine

    Uterine Cervical Neoplasms

    phase 3 small molecule active

    1 trial

  12. Conivaptan hydrochloride

    CUMBERLAND PHARMACEUTICALS INC

    Hyponatremia

    phase 3 small molecule terminated

    1 trial

  13. Continuous Gastrocnemius plane block with ropivacaine

    The First People's Hospital of Lianyungang

    Foot Ankle Injuries

    phase 3 small molecule active

    1 trial

  14. Control

    Hospital Authority, Hong Kong

    Hallucinations, Verbal Auditory

    phase 3 small molecule active

    1 trial

  15. Conventional medical treatment

    Lxo Ireland Designated Activity Company

    Coronary Atherosclerosis and Other Heart Disease

    phase 3 small molecule completed

    1 trial

  16. Conventional sound generator (SG)

    Camp4 Therapeutics Corp

    Subjective Tinnitus

    phase 3 other completed

    1 trial

  17. Copanlisib (Aliqopa, BAY80-6946)

    Bayer HealthCare AG

    Lymphoma,Non-Hodgkin

    phase 3 small molecule completed

    1 trial

  18. Coronary Artery Bypass Graft with the use of CPB

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    the Efficacy and Safety of Off-pump CABG

    phase 3 other completed

    1 trial

  19. Coronary CTA

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease

    phase 3 other completed

    1 trial

  20. Coronary artery bypass grafting

    Rhythm Pharmaceuticals Netherlands B.V.

    Ischemic Heart Failure

    phase 3 other completed

    1 trial

  21. Counseling + Transfer

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Addiction

    phase 3 small molecule completed

    1 trial

  22. Crenezumab

    Hoffmann-La Roche

    Alzheimer's Disease

    phase 3 small molecule terminated

    1 trial

  23. Cretostimogene Grenadenorepvec

    CG Oncology

    Non Muscle Invasive Bladder Cancer

    phase 3 mab active

    2 trials

  24. Crinecerfont

    NEUROCRINE BIOSCIENCES INC

    Congenital Adrenal Hyperplasia

    phase 3 small molecule active

    4 trials

  25. Crovalimab

    Hoffmann-La Roche

    Atypical Hemolytic Uremic Syndrome (aHUS)

    phase 3 small molecule active

    1 trial

  26. Crovalimab

    Hoffmann-La Roche

    Paroxysmal Nocturnal Hemoglobinuria

    phase 3 small molecule active

    1 trial

  27. Crovalimab, Crovalimab

    Hoffmann-La Roche

    Atypical Hemolytic Uremic Syndrome (aHUS)

    phase 3 small molecule active

    1 trial

  28. Cryo-Touch II

    Pacira Ireland Limited

    Facial Wrinkles

    phase 3 other completed

    2 trials

  29. Cryo-Touch III

    Pacira Ireland Limited

    Facial Wrinkles

    phase 3 other completed

    1 trial

  30. Crystalline cellulose simple occlusive dressing

    The First People's Hospital of Lianyungang

    Split-thickness Skin Graft Donor Sites

    phase 3 other completed

    1 trial

  31. Custirsen

    Teva Pharma GmbH

    Prostate Cancer

    phase 3 small molecule completed

    1 trial

  32. Cx601

    Takeda

    Crohn's Disease

    phase 3 other completed

    3 trials

  33. Cyclobenzaprine HCl

    Takeda

    Neck Pain

    phase 3 small molecule completed

    1 trial

  34. Cyclophosphamide

    Children's Hospital of Fudan University

    Stage III Kidney Wilms Tumor

    phase 3 small molecule active

    1 trial

  35. Cyproterone acetate

    Takeda

    Adenocarcinoma, Prostate

    phase 3 small molecule completed

    1 trial

  36. Cytarabine

    The First People's Hospital of Lianyungang

    Leukemia

    phase 3 small molecule active

    1 trial

  37. Cytarabine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    AML

    phase 3 small molecule active

    3 trials

  38. Cytarabine

    Hoffmann-La Roche

    Leukemia, Myeloid, Acute

    phase 3 small molecule terminated

    1 trial

  39. Cytarabine

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  40. Cytokine-Induced Killer Cells

    Sun Yat-sen University

    Carcinoma, Hepatocellular

    phase 3 mab completed

    1 trial

  41. D-US-60010-001

    Ipsen

    Metastatic Pancreatic Adenocarcinoma

    phase 3 small molecule active

    1 trial

  42. D-cycloserine

    United Therapeutics Europe Ltd

    Autistic Disorder

    phase 3 small molecule completed

    1 trial

  43. D0817C00098

    AstraZeneca AB

    BRCA Mutated Ovarian Cancer Patients, Epithelian ovarian cancer, Metastatic Breast Cancer, Platinum Sensitive Relapsed Ovarian Cancer, Patients with gBRCA mutated metastatic pancreatic cancer, prostate cancer, endometrium cancer

    phase 3 small molecule active

    1 trial

  44. D081CC00006

    AstraZeneca AB

    Breast Cancer

    phase 3 small molecule active

    1 trial

  45. D1447C00001

    AstraZeneca

    Bipolar Disorder

    phase 3 small molecule completed

    1 trial

  46. D20180102

    Pari Pharma GmbH

    Vascular calcification and type 1 diabetes

    phase 3 small molecule active

    1 trial

  47. D20180135

    Pari Pharma GmbH

    Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome

    phase 3 small molecule active

    1 trial

  48. D20180177

    Pari Pharma GmbH

    Pancreatic adenocarcinoma (PAC)

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.